{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:57:25Z","timestamp":1789567045686,"version":"build-2803163510"},"reference-count":81,"publisher":"Bioscientifica","issue":"3","content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,1]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Diabetic osteoporosis is a metabolic disease that seriously endangers human health, and previous studies have found that denosumab and metformin have certain effects on bone metabolism and glucose metabolism, respectively. However, there is still a lack of relevant research on the effect of the combined use of the two drugs. In this study, we sought to analyze the therapeutic effect of these two drugs combined on glycemic and bone metabolic parameters in the treatment of type 2 diabetes with postmenopausal osteoporosis. A prospective cohort study was designed to include 537 cases of patients with type 2 diabetes and postmenopausal osteoporosis. Patients were treated with placebo alone (placebo, n = 135), metformin alone (MET, n = 132), denosumab alone (DEN, n = 136), and the combination group (n = 134) for 30 months. Baseline data at 10, 20, and 30 months, dual-energy X-ray absorptiometry (DEXA), and pQCT were used to identify spine and tibia bone microstructures, respectively. The combination therapy group demonstrated significantly greater improvements in bone mineral density (tibia, radius, spine, and whole body) and bone microstructure (tibia and radius) compared to MET or DEN monotherapy (P &amp;lt; 0.05). Bone resorption markers such as CTX and ALP were decreased, the level of bone formation markers was further increased, and the progression of glucose metabolism was significantly improved (P &amp;lt; 0.05) compared to DEN alone or Met alone. Denosumab monotherapy (DEN) ameliorated bone loss while exerting modest effects on glucose metabolism progression. In contrast, metformin monotherapy (MET) significantly improved glycemic control but demonstrated limited efficacy against bone loss. Crucially, the metformin-denosumab combination synergistically mitigated bone loss in diabetic postmenopausal osteoporosis patients.<\/jats:p>\n                    <jats:sec>\n                      <jats:title>Keypoints<\/jats:title>\n                    <\/jats:sec>\n                  <\/jats:sec>","DOI":"10.1530\/joe-25-0081","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:13:00Z","timestamp":1757592780000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-5","source":"Crossref","is-referenced-by-count":4,"title":["Effects of metformin and denosumab on bone and glucose metabolism in postmenopausal women with osteoporosis and diabetes"],"prefix":"10.1530","volume":"266","author":[{"given":"Xiao","family":"Jin","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Immunology, Xuzhou Municipal Hospital Affiliated with Xuzhou Medical University 1 , , ,","place":["Xuzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Emergency Surgery, The First Affiliated Hospital of Harbin Medical University 2 , ,","place":["Harbin, PR China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BaoGuo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Xuzhou Municipal Hospital Affiliated with Xuzhou Medical University 1 , , ,","place":["Xuzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiani","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Xuzhou Municipal Hospital Affiliated with Xuzhou Medical University 1 , , ,","place":["Xuzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, The Shanghai Tenth People\u2019s Hospital Chongming Branch, School of Medicine, Tongji University 3 , ,","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Shang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Xuzhou Municipal Hospital Affiliated with Xuzhou Medical University 1 , , ,","place":["Xuzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Xuzhou Municipal Hospital Affiliated with Xuzhou Medical University 1 , , ,","place":["Xuzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6053-2717","authenticated-orcid":true,"given":"Zhiqiang","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Xuzhou Municipal Hospital Affiliated with Xuzhou Medical University 4 , , ,","place":["Xuzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"key":"2026070806114602600_bib1","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2174\/1570161116666180625124405","article-title":"Diabetes in menopause: risks and management","volume":"17","author":"Paschou","year":"2019","journal-title":"Curr Vasc Pharmacol"},{"key":"2026070806114602600_bib2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.maturitas.2019.05.003","article-title":"Therapeutic strategies for type 2 diabetes mellitus in women after menopause","volume":"126","author":"Paschou","year":"2019","journal-title":"Maturitas"},{"key":"2026070806114602600_bib3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"2026070806114602600_bib4","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/ejcn.2017.133","article-title":"The association between dietary inflammatory properties and bone mineral density and risk of fracture in US adults","volume":"71","author":"Mazidi","year":"2017","journal-title":"Eur J Clin Nutr"},{"key":"2026070806114602600_bib5","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1210\/jc.2019-00576","article-title":"Association between urinary triclosan with bone mass density and osteoporosis in US adult women, 2005\u20132010","volume":"104","author":"Cai","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070806114602600_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1530\/EJE-18-0602","article-title":"Early menopause and premature ovarian insufficiency are associated with increased risk of type 2 diabetes: a systematic review and meta-analysis","volume":"180","author":"Anagnostis","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"2026070806114602600_bib7","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/jbmr.4780","article-title":"The clinical and skeletal effects of long-term therapy of hypoparathyroidism with rhPTH (1\u201384)","volume":"38","author":"Agarwal","year":"2023","journal-title":"J Bone Miner Res"},{"key":"2026070806114602600_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jbmr.4739","article-title":"Teriparatide followed by denosumab in premenopausal idiopathic osteoporosis: bone microstructure and strength by HR-pQCT","volume":"38","author":"Agarwal","year":"2023","journal-title":"J Bone Miner Res"},{"key":"2026070806114602600_bib9","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/jbmr.4732","article-title":"Conditional loss of Nmp4 in mesenchymal stem progenitor cells enhances PTH-induced bone formation","volume":"38","author":"Atkinson","year":"2023","journal-title":"J Bone Miner Res"},{"key":"2026070806114602600_bib10","doi-asserted-by":"crossref","first-page":"e791","DOI":"10.1210\/clinem\/dgae240","article-title":"Bisphosphonates maintain BMD after sequential teriparatide and denosumab in premenopausal women with idiopathic osteoporosis","volume":"110","author":"Kamanda-Kosseh","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070806114602600_bib11","first-page":"333","article-title":"Diabetes mellitus and osteoporosis","volume":"44","author":"Paschou","year":"2019","journal-title":"Minerva Endocrinol"},{"key":"2026070806114602600_bib12","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1210\/jc.2017-00042","article-title":"Type 2 diabetes and osteoporosis: a guide to optimal management","volume":"102","author":"Paschou","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070806114602600_bib13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00223-016-0177-8","article-title":"Efficacy of osteoporosis therapies in diabetic patients","volume":"100","author":"Schwartz","year":"2017","journal-title":"Calcif Tissue Int"},{"key":"2026070806114602600_bib14","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/CCM.0000000000005468","article-title":"Association of metformin use during hospitalization and mortality in critically ill adults with type 2 diabetes mellitus and sepsis","volume":"50","author":"G\u00f3mez","year":"2022","journal-title":"Crit Care Med"},{"key":"2026070806114602600_bib15","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1161\/CIRCULATIONAHA.121.056756","article-title":"Effects of long-term metformin and lifestyle interventions on cardiovascular events in the diabetes prevention program and its outcome study","volume":"145","author":"Goldberg","year":"2022","journal-title":"Circulation"},{"key":"2026070806114602600_bib16","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/jama.2022.0078","article-title":"Effect of subcutaneous tirzepatide vs placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes: the SURPASS-5 randomized clinical trial","volume":"327","author":"Dahl","year":"2022","journal-title":"JAMA"},{"key":"2026070806114602600_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/pedi.12473","article-title":"Metformin; a review of its history and future: from lilac to longevity","volume":"18","author":"Thomas","year":"2017","journal-title":"Pediatr Diabetes"},{"key":"2026070806114602600_bib18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejphar.2006.02.030","article-title":"Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture","volume":"536","author":"Cortizo","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"2026070806114602600_bib19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1359\/jbmr.090732","article-title":"Effect of metformin on bone marrow progenitor cell differentiation: in vivo and in vitro studies","volume":"25","author":"Molinuevo","year":"2010","journal-title":"J Bone Miner Res"},{"key":"2026070806114602600_bib20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ejphar.2010.02.051","article-title":"Effect of the anti-diabetic drug metformin on bone mass in ovariectomized rats","volume":"635","author":"Gao","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"2026070806114602600_bib21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ejphar.2011.07.033","article-title":"Metformin prevents anti-osteogenic in vivo and ex vivo effects of rosiglitazone in rats","volume":"668","author":"Sedlinsky","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"2026070806114602600_bib22","doi-asserted-by":"crossref","first-page":"272","DOI":"10.18632\/aging.203729","article-title":"The effects of metformin and alendronate in attenuating bone loss and improving glucose metabolism in diabetes mellitus mice","volume":"14","author":"Zhou","year":"2022","journal-title":"Aging"},{"key":"2026070806114602600_bib23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jbspin.2018.08.002","article-title":"Bone disorders associated with diabetes mellitus and its treatments","volume":"86","author":"Cortet","year":"2019","journal-title":"Joint Bone Spine"},{"key":"2026070806114602600_bib24","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S2213-8587(17)30138-9","article-title":"10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension","volume":"5","author":"Bone","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026070806114602600_bib25","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0140-6736(21)02646-5","article-title":"Drug therapy for osteoporosis in older adults","volume":"399","author":"Reid","year":"2022","journal-title":"Lancet"},{"key":"2026070806114602600_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-073435","article-title":"Denosumab and incidence of type 2 diabetes among adults with osteoporosis: population based cohort study","volume":"381","author":"Lyu","year":"2023","journal-title":"BMJ"},{"key":"2026070806114602600_bib27","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.54734","article-title":"Denosumab and the risk of diabetes in patients treated for osteoporosis","volume":"7","author":"Huang","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026070806114602600_bib28","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3390\/jcm10050996","article-title":"The impact of antiosteoporotic drugs on glucose metabolism and fracture risk in diabetes: good or bad news?","volume":"10","author":"Anastasilakis","year":"2021","journal-title":"J Clin Med"},{"key":"2026070806114602600_bib29","doi-asserted-by":"crossref","first-page":"816","DOI":"10.2337\/dc18-1953","article-title":"Seasonal variations in the achievement of guideline targets for HbA(1c), blood pressure, and cholesterol among patients with type 2 diabetes: a nationwide population-based study (ABC study: JDDM49)","volume":"42","author":"Sakamoto","year":"2019","journal-title":"Diabetes Care"},{"key":"2026070806114602600_bib30","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1080\/14712598.2019.1618266","article-title":"An update on therapies for the treatment of diabetes-induced osteoporosis","volume":"19","author":"Mohsin","year":"2019","journal-title":"Expet Opin Biol Ther"},{"key":"2026070806114602600_bib31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/21556660.2011.641703","article-title":"Mechanism of action study to evaluate the effect of rosiglitazone on bone in postmenopausal women with type 2 diabetes mellitus: rationale, study design and baseline characteristics","volume":"1","author":"Fitzpatrick","year":"2012","journal-title":"J Drug Assess"},{"key":"2026070806114602600_bib32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jbmr.2315","article-title":"Comparative effects of teriparatide, denosumab, and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: the DATA-HRpQCT Study","volume":"30","author":"Tsai","year":"2015","journal-title":"J Bone Miner Res"},{"key":"2026070806114602600_bib33","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"2026070806114602600_bib34","first-page":"1117","article-title":"Update on osteoporosis screening and management","volume":"105","author":"Anam","year":"2021","journal-title":"Med Clin"},{"key":"2026070806114602600_bib35","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1359\/jbmr.070510","article-title":"Osteoporosis in patients with diabetes mellitus","volume":"22","author":"Hofbauer","year":"2007","journal-title":"J Bone Miner Res"},{"key":"2026070806114602600_bib36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40520-014-0258-3","article-title":"The prevention of fragility fractures in diabetic patients","volume":"27","author":"Gonnelli","year":"2015","journal-title":"Aging Clin Exp Res"},{"key":"2026070806114602600_bib37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s40200-018-0359-1","article-title":"Effect of type 2 diabetes mellitus on treatment outcomes of patients with postmenopausal osteoporosis: a retrospective study","volume":"17","author":"Yilmaz","year":"2018","journal-title":"J Diabetes Metab Disord"},{"key":"2026070806114602600_bib38","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1152\/ajpendo.00157.2010","article-title":"The many facets of PPARgamma: novel insights for the skeleton","volume":"299","author":"Kawai","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2026070806114602600_bib39","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41467-019-14003-6","article-title":"Identification of osteoclast-osteoblast coupling factors in humans reveals links between bone and energy metabolism","volume":"11","author":"Weivoda","year":"2020","journal-title":"Nat Commun"},{"key":"2026070806114602600_bib40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrendo.2011.233","article-title":"Bone, sweet bone \u2013 osteoporotic fractures in diabetes mellitus","volume":"8","author":"Hamann","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"2026070806114602600_bib41","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1139\/o05-163","article-title":"Effects of glucose and its modulation by insulin and estradiol on BMSC differentiation into osteoblastic lineages","volume":"84","author":"Gopalakrishnan","year":"2006","journal-title":"Biochem Cell Biol"},{"key":"2026070806114602600_bib42","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jamaneurol.2025.1522","article-title":"Global, regional, and national burden of nontraumatic subarachnoid hemorrhage: the global burden of disease study 2021","volume":"82","author":"Rautalin","year":"2025","journal-title":"JAMA Neurol"},{"key":"2026070806114602600_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101040","article-title":"Roles of bone-derived hormones in type 2 diabetes and cardiovascular pathophysiology","volume":"40","author":"Lin","year":"2020","journal-title":"Mol Metabol"},{"key":"2026070806114602600_bib44","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.cmet.2024.03.006","article-title":"An integrated multi-omics analysis reveals osteokines involved in global regulation","volume":"36","author":"Liang","year":"2024","journal-title":"Cell Metab"},{"key":"2026070806114602600_bib45","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.bone.2011.04.017","article-title":"Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice","volume":"50","author":"Ferron","year":"2012","journal-title":"Bone"},{"key":"2026070806114602600_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2024.117048","article-title":"Osteocalcin improves glucose tolerance, insulin sensitivity and secretion in older male mice","volume":"182","author":"Paracha","year":"2024","journal-title":"Bone"},{"key":"2026070806114602600_bib47","doi-asserted-by":"crossref","DOI":"10.1177\/20420188231170754","article-title":"RANKL inhibition: a new target of treating diabetes mellitus?","volume":"14","author":"Xing","year":"2023","journal-title":"Ther Adv Endocrinol Metab"},{"key":"2026070806114602600_bib48","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/jc.2011-2186","article-title":"Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus","volume":"97","author":"Garc\u00eda-Mart\u00edn","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070806114602600_bib49","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1210\/jc.2011-2958","article-title":"Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes","volume":"97","author":"Gennari","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070806114602600_bib50","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000018067","article-title":"Effect of denosumab, a human monoclonal antibody of receptor activator of nuclear factor kappa-B ligand (RANKL), upon glycemic and metabolic parameters: effect of denosumab on glycemic parameters","volume":"98","author":"Abe","year":"2019","journal-title":"Medicine"},{"key":"2026070806114602600_bib51","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.peptides.2017.11.023","article-title":"Dipeptidyl peptidase inhibitor therapy in type 2 diabetes: control of the incretin axis and regulation of postprandial glucose and lipid metabolism","volume":"100","author":"Mulvihill","year":"2018","journal-title":"Peptides"},{"key":"2026070806114602600_bib52","article-title":"Dipeptidyl peptidase-4 inhibitors and fracture risk: an updated meta-analysis of randomized clinical trials","volume":"6","author":"Fu","year":"2016","journal-title":"Sci Rep"},{"key":"2026070806114602600_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187537","article-title":"The effects of dipeptidyl peptidase-4 inhibitors on bone fracture among patients with type 2 diabetes mellitus: a network meta-analysis of randomized controlled trials","volume":"12","author":"Yang","year":"2017","journal-title":"PLoS One"},{"key":"2026070806114602600_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2025.117526","article-title":"Linagliptin-metformin combination: A novel approach to mitigate 4-vinyl cyclohexene di epoxide and dexamethasone-induced osteoporosis in mice","volume":"198","author":"Nirwan","year":"2025","journal-title":"Bone"},{"key":"2026070806114602600_bib55","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s00125-005-1786-3","article-title":"Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk","volume":"48","author":"Vestergaard","year":"2005","journal-title":"Diabetologia"},{"key":"2026070806114602600_bib56","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1210\/jc.2009-0572","article-title":"Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes","volume":"95","author":"Zinman","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070806114602600_bib57","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bbrc.2008.08.034","article-title":"Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression","volume":"375","author":"Kanazawa","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"2026070806114602600_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2025.123526","article-title":"A multifunctional metformin loaded carboxymethyl chitosan\/tannic acid\/manganese composite hydrogel with promising capabilities for age-related bone defect repair","volume":"358","author":"Chen","year":"2025","journal-title":"Carbohydr Polym"},{"key":"2026070806114602600_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdent.2025.105787","article-title":"Metformin\u2019s mechanism in reducing oxidative stress and promoting bone regeneration in T2DM rat BMMSCs: a focus on NRF2-GPX7 signaling pathway","volume":"158","author":"Dong","year":"2025","journal-title":"J Dent"},{"key":"2026070806114602600_bib60","article-title":"Metformin attenuates diabetic osteoporosis by suppressing ferroptosis via the AMPK\/Nrf2 pathway","volume":"16","author":"Liu","year":"2025","journal-title":"Front Pharmacol"},{"key":"2026070806114602600_bib61","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s10020-025-01169-7","article-title":"Metformin ameliorates osteoporosis by enhancing bone angiogenesis via the YAP1\/TAZ-HIF1\u03b1 axis","volume":"31","author":"Yin","year":"2025","journal-title":"Mol Med"},{"key":"2026070806114602600_bib62","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/jbmr.1865","article-title":"Effects of antiresorptive therapies on glucose metabolism: results from the FIT, HORIZON-PFT, and FREEDOM trials","volume":"28","author":"Schwartz","year":"2013","journal-title":"J Bone Miner Res"},{"key":"2026070806114602600_bib63","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1172\/JCI125915","article-title":"RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass","volume":"129","author":"Bonnet","year":"2019","journal-title":"J Clin Invest"},{"key":"2026070806114602600_bib64","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nm.3084","article-title":"Blockade of receptor activator of nuclear factor-\u03baB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus","volume":"19","author":"Kiechl","year":"2013","journal-title":"Nat Med"},{"key":"2026070806114602600_bib65","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cmet.2015.05.021","article-title":"Osteoprotegerin and denosumab stimulate human beta cell proliferation through inhibition of the receptor activator of NF-\u03baB ligand pathway","volume":"22","author":"Kondegowda","year":"2015","journal-title":"Cell Metab"},{"key":"2026070806114602600_bib66","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41574-020-0355-7","article-title":"Pancreatic \u03b2-cells in type 1 and type 2 diabetes mellitus: different pathways to failure","volume":"16","author":"Eizirik","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"2026070806114602600_bib67","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/jdi.14002","article-title":"Signaling pathways that regulate adaptive \u03b2-cell proliferation for the treatment of diabetes","volume":"14","author":"Shirakawa","year":"2023","journal-title":"J Diabetes Invest"},{"key":"2026070806114602600_bib68","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1007\/s00125-017-4336-x","article-title":"Metformin: clinical use in type 2 diabetes","volume":"60","author":"Sanchez-Rangel","year":"2017","journal-title":"Diabetologia"},{"key":"2026070806114602600_bib69","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00774-014-0581-y","article-title":"Evaluation of the anti-osteoporotic effects of metformin and sitagliptin in postmenopausal diabetic women","volume":"33","author":"Hegazy","year":"2015","journal-title":"J Bone Miner Metabol"},{"key":"2026070806114602600_bib70","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1007\/s00198-013-2371-0","article-title":"The anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing","volume":"24","author":"Jeyabalan","year":"2013","journal-title":"Osteoporos Int"},{"key":"2026070806114602600_bib71","doi-asserted-by":"crossref","first-page":"E1933","DOI":"10.1210\/jc.2013-3666","article-title":"Effects of rosiglitazone vs metformin on circulating osteoclast and osteogenic precursor cells in postmenopausal women with type 2 diabetes mellitus","volume":"99","author":"Rubin","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070806114602600_bib72","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1002\/jcb.23206","article-title":"Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats","volume":"112","author":"Mai","year":"2011","journal-title":"J Cell Biochem"},{"key":"2026070806114602600_bib73","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s00125-014-3289-6","article-title":"Fracture risk in diabetic elderly men: the MrOS study","volume":"57","author":"Napoli","year":"2014","journal-title":"Diabetologia"},{"key":"2026070806114602600_bib74","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5294266","article-title":"Metformin and tBHQ treatment combined with an exercise regime prevents osteosarcopenic obesity in middle-aged wistar female rats","volume":"2021","author":"Toledo-P\u00e9rez","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"2026070806114602600_bib75","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41584-022-00887-0","article-title":"The decisive early phase of bone regeneration","volume":"19","author":"Duda","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"2026070806114602600_bib76","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41575-025-01075-7","article-title":"Menopause and gastrointestinal health and disease","volume":"22","author":"Ley","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026070806114602600_bib77","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41413-025-00428-x","article-title":"Age- and sex-specific deterioration on bone and osteocyte lacuno-canalicular network in a mouse model of premature aging","volume":"13","author":"Y\u0131lmaz","year":"2025","journal-title":"Bone Res"},{"key":"2026070806114602600_bib78","first-page":"3387","article-title":"Metformin promotes cell proliferation and osteogenesis under high glucose condition by regulating the ROS-AKT-mTOR axis","volume":"22","author":"Zhou","year":"2020","journal-title":"Mol Med Rep"},{"key":"2026070806114602600_bib79","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/cbin.11202","article-title":"Metformin facilitates the proliferation, migration, and osteogenic differentiation of periodontal ligament stem cells in vitro","volume":"44","author":"Zhang","year":"2019","journal-title":"Cell Biol Int"},{"key":"2026070806114602600_bib80","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.lfs.2018.11.008","article-title":"Metformin alleviates hyperglycemia-induced apoptosis and differentiation suppression in osteoblasts through inhibiting the TLR4 signaling pathway","volume":"216","author":"Zheng","year":"2019","journal-title":"Life Sci"},{"key":"2026070806114602600_bib81","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.bbrc.2020.06.146","article-title":"Metformin promotes the osseointegration of titanium implants under osteoporotic conditions by regulating BMSCs autophagy, and osteogenic differentiation","volume":"531","author":"Lin","year":"2020","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/joe.bioscientifica.com\/view\/journals\/joe\/266\/3\/JOE-25-0081.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/joe.bioscientifica.com\/downloadpdf\/journals\/joe\/266\/3\/JOE-25-0081.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/joe\/article-pdf\/doi\/10.1530\/JOE-25-0081\/44839\/joe-25-0081.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/joe\/article-pdf\/doi\/10.1530\/JOE-25-0081\/44839\/joe-25-0081.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T10:12:01Z","timestamp":1783505521000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/joe\/article\/266\/3\/e250081\/5713\/Effects-of-metformin-and-denosumab-on-bone-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":81,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9,1]]}},"URL":"https:\/\/doi.org\/10.1530\/joe-25-0081","relation":{},"ISSN":["1479-6805","0022-0795"],"issn-type":[{"value":"1479-6805","type":"electronic"},{"value":"0022-0795","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"article-number":"e250081"}}